Lysosome storage disorders on the brain: The autophagy lysosome pathway contributes to disease pathophysiology and may be utilized for therapeutic benefit

Autophagy of the Nervous System: Cellular Self-Digestion in Neurons and Neurological Diseases

Volumn , Issue , 2012, Pages 331-354

  Shacka, John J ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971216516     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814350457_0014     Document Type: Chapter

References (83)

1. J. Ezaki and E. Kominami, The intracellular location and function of proteins of neuronal ceroid lipofuscinoses, Brain Pathol 14: 77-85 (2004).
2. J. J. Shacka and K. A. Roth, Cathepsin deficiency as a model for neuronal ceroid lipofuscinoses, Am J Pathol 167: 1473-1476 (2005).
3. J. J. Shacka and K. A. Roth, Cathepsin D deficiency and NCL/Batten disease: there’s more to death than apoptosis, Autophagy 3: 474-476 (2007).
4. Y. Sun, B. Liou, H. Ran, M. R. Skelton, M. T. Williams, C. V. Vorhees, K. Kitatani, Y. A. Hannun, D. P. Witte, Y. H. Xu and G. A. Grabowski, Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits, Hum Mol Genet 19: 1088-1097 (2010).
5. Y. Sun and G. A. Grabowski, Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease, Autophagy 6: 648-649 (2010).
6. M. Chevrier, N. Brakch, C. Lesueur, D. Genty, Y. Ramdani, S. Moll, M. Djavaheri-Mergny, C. Brasse-Lagnel, A. Laquerriere, F. Barbey and S. Bekri, Autophagosome maturation is impaired in Fabry disease, Autophagy 6: 589-599 (2010).
7. J. R. Berger, D. A. Dillon, B. A. Young, S. J. Goldstein and P. Nelson, Cystinosis of the brain and spinal cord with associated vasculopathy, J Neurol Sci 284: 182-185 (2009).
8. D. C. Ko, L. Milenkovic, S. M. Beier, H. Manuel, J. Buchanan and M. P. Scott, Cell-autonomous death of cerebellar purkinje neurons with autophagy in Niemann-Pick type C disease, PLoS Genet 1: 81-95 (2005).
9. J. J. Higgins, M. C. Patterson, J. M. Dambrosia, A. T. Pikus, P. G. Pentchev, S. Sato, R. O. Brady and N. W. Barton, A clinical staging classification for type C Niemann-Pick disease, Neurology 42: 2286-2290 (1992).
10. A. Takamura, K. Higaki, K. Kajimaki, S. Otsuka, H. Ninomiya, J. Matsuda, K. Ohno, Y. Suzuki and E. Nanba, Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis, Biochem Biophys Res Commun 367: 616-622 (2008).
11. T. Kolter and K. Sandhoff, Sphingolipid metabolism diseases, Biochim Biophys Acta 1758: 2057-2079 (2006).
12. C. Settembre, I. Annunziata, C. Spampanato, D. Zarcone, G. Cobellis, E. Nusco, E. Zito, C. Tacchetti, M. P. Cosma and A. Ballabio, Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency, Proc Natl Acad Sci USA 104: 4506-4511 (2007).
13. M. J. Valstar, H. T. Bruggenwirth, R. Olmer, R. A. Wevers, F. W. Verheijen, B. J. Poorthuis, D. J. Halley and F. A. Wijburg, Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype, J Inherit Metab Dis 33: 759-767 (2010).
14. C. Settembre, A. Fraldi, L. Jahreiss, C. Spampanato, C. Venturi, D. Medina, R. de Pablo, C. Tacchetti, D. C. Rubinsztein and A. Ballabio, A block of autophagy in lysosomal storage disorders, Hum Mol Genet 17: 119-129 (2008).
15. A. Tessitore, M. Pirozzi and A. Auricchio, Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI, Pathogenetics 2: 4 (2009).
16. G. Altarescu, M. Sun, D. F. Moore, J. A. Smith, E. A. Wiggs, B. I. Solomon, N. J. Patronas, K. P. Frei, S. Gupta, C. R. Kaneski, O. W. Quarrell, S. A. Slaugenhaupt, E. Goldin and R. Schiffmann, The neurogenetics of mucolipidosis type IV, Neurology 59: 306-313 (2002).
17. J. J. Jennings, Jr., J. H. Zhu, Y. Rbaibi, X. Luo, C. T. Chu and K. Kiselyov, Mitochondrial aberrations in mucolipidosis Type IV, J Biol Chem 281: 39041-39050 (2006).
18. S. Vergarajauregui, P. S. Connelly, M. P. Daniels and R. Puertollano, Autophagic dysfunction in mucolipidosis type IV patients, Hum Mol Genet 17: 2723-2737 (2008).
19. T. Otomo, K. Higaki, E. Nanba, K. Ozono and N. Sakai, Inhibition of autophagosome formation restores mitochondrial function in mucolipidosis II and III skin fibroblasts, Mol Genet Metab 98: 393-399 (2009).
20. X. P. Dong, X. Cheng, E. Mills, M. Delling, F. Wang, T. Kurz and H. Xu, The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel, Nature 455: 992-996 (2008).
21. J. L. Eichelsdoerfer, J. A. Evans, S. A. Slaugenhaupt and M. P. Cuajungco, Zinc dyshomeostasis is linked with the loss of mucolipidosis IV-associated TRPML1 ion channel, J Biol Chem 285: 34304-34308 (2010).
22. T. Fukuda, A. Roberts, M. Ahearn, K. Zaal, E. Ralston, P. H. Plotz and N. Raben, Autophagy and lysosomes in Pompe disease, Autophagy 2: 318-320 (2006).
23. L. R. DeRuisseau, D. D. Fuller, K. Qiu, K. C. DeRuisseau, W. H. Donnelly, Jr., C. Mah, P. J. Reier and B. J. Byrne, Neural deficits contribute to respiratory insufficiency in Pompe disease, Proc Natl Acad Sci USA 106: 9419-9424 (2009).
24. P. Saftig, W. Beertsen and E. L. Eskelinen, LAMP-2: a control step for phagosome and autophagosome maturation, Autophagy 4: 510-512 (2008).
25. Y. K. Bui, P. Renella, J. A. Martinez-Agosto, A. Verity, A. Madikians and J. C. Alejos, Danon disease with typical early-onset cardiomyopathy in a male: focus on a novel LAMP-2 mutation, Pediatr Transplant 12: 246-250 (2008).
26. H. Kim, A. Cho, B. C. Lim, M. J. Kim, K. J. Kim, I. Nishino, Y. S. Hwang and J. H. Chae, A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease, Muscle Nerve 41: 879-882 (2010).
27. E. L. Eskelinen and P. Saftig, Autophagy: a lysosomal degradation pathway with a central role in health and disease, Biochim Biophys Acta 1793: 664-673 (2009).
28. R. A. Nixon, D. S. Yang and J. H. Lee, Neurodegenerative lysosomal disorders — a continuum from development to late age, Autophagy 4: 590-599 (2008).
29. Y. Kabeya, N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, T. Noda, E. Kominami, Y. Ohsumi and T. Yoshimori, LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing, EMBO J 19: 5720-5728 (2000).
30. H. M. Ni, A. Bockus, A. L. Wozniak, K. Jones, S. Weinman, X. M. Yin and W. X. Ding, Dissecting the dynamic turnover of GFP-LC3 in the autolysosome, Autophagy 7: 188-204 (2011).
31. D. J. Klionsky, H. Abeliovich, P. Agostinis, D. K. Agrawal, et al., Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes, Autophagy 4: 151-175 (2007).
32. T. Fukuda, L. Ewan, M. Bauer, R. J. Mattaliano, K. Zaal, E. Ralston, P. H. Plotz and N. Raben, Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease, Ann Neurol 59: 700-708 (2006).
33. N. Raben, V. Hill, L. Shea, S. Takikita, R. Baum, N. Mizushima, E. Ralston and P. Plotz, Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease, Hum Mol Genet 17: 3897-3908 (2008).
34. A. Fidzianska, E. Walczak and M. Walski, Abnormal chaperone-mediated autophagy (CMA) in cardiomyocytes of a boy with Danon disease, Folia Neuropathol 45: 133-139 (2007).
35. B. Boland, D. A. Smith, D. Mooney, S. S. Jung, D. M. Walsh and F. M. Platt, Macroautophagy is not directly involved in the metabolism of amyloid precursor protein, J Biol Chem 285: 37415-37428 (2010).
36. M. Koike, H. Nakanishi, P. Saftig, J. Ezaki, K. Isahara, Y. Ohsawa, W. Schulz-Schaeffer, T. Watanabe, S. Waguri, S. Kametaka, M. Shibata, K. Yamamoto, E. Kominami, C. Peters, K. von Figura and Y. Uchiyama, Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons, J Neurosci 20: 6898-6906 (2000).
37. M. Koike, M. Shibata, S. Waguri, K. Yoshimura, I. Tanida, E. Kominami, T. Gotow, C. Peters, K. von Figura, N. Mizushima, P. Saftig and Y. Uchiyama, Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease), Am J Pathol 167: 1713-1728 (2005).
38. T. Hara, K. Nakamura, M. Matsui, A. Yamamoto, Y. Nakahara, R. Suzuki-Migishima, M. Yokoyama, K. Mishima, I. Saito, H. Okano and N. Mizushima, Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice, Nature 441: 885-889 (2006).
39. G. Bj0rk0y, T. Lamark, A. Brech, H. Outzen, M. Perander, A. 0vervatn, H. Stenmark and T. Johansen, p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death, J Cell Biol 171: 603-614 (2005).
40. A. M. Vaccaro, M. Motta, M. Tatti, S. Scarpa, L. Masuelli, M. Bhat, M. T. Vanier, A. Tylki-Szymanska and R. Salvioli, Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting, Hum Mol Genet 19: 2987-2997 (2010).
41. S. Vergarajauregui and R. Puertollano, Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy, Autophagy 4: 832-834 (2008).
42. G. Liao, Y. Yao, J. Liu, Z. Yu, S. Cheung, A. Xie, X. Liang and X. Bi, Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain, Am J Pathol 171: 962-975 (2007).
43. L. Qiao, S. Hamamichi, K. A. Caldwell, G. A. Caldwell, T. A. Yacoubian, S. Wilson, Z. L. Xie, L. D. Speake, R. Parks, D. Crabtree, Q. Liang, S. Crimmins, L. Schneider, Y. Uchiyama, T. Iwatsubo, Y. Zhou, L. Peng, Y. Lu, D. G. Standaert, K. C. Walls, J. J. Shacka, K. A. Roth and J. Zhang, Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity, Mol Brain 1: 1-18 (2008).
44. V. Cullen, M. Lindfors, J. Ng, A. Paetau, E. Swinton, P. Kolodziej, H. Boston, P. Saftig, J. Woulfe, M. B. Feany, L. Myllykangas, M. G. Schlossmacher and J. Tyynela, Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo, Mol Brain 2: 1-17 (2009).
45. C. D. Pacheco, R. Kunkel and A. P. Lieberman, Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects, Hum Mol Genet 16: 1495-1503 (2007).
46. N. Mizushima and T. Yoshimori, How to interpret LC3 immunoblotting, Autophagy 3: 542-545 (2007).
47. C. Settembre, A. Fraldi, L. Jahreiss, C. Spampanato, C. Venturi, D. Medina, R. de Pablo, C. Tacchetti, D. C. Rubinsztein and A. Ballabio, A block of autophagy in lysosomal storage disorders, Hum Mol Genet 17: 119-129 (2007).
48. X. S. Xie, D. Padron, X. Liao, J. Wang, M. G. Roth and J. K. de Brabander, Salicylihalamide A inhibits the V0 sector of the V-ATPase through a mechanism distinct from bafilomycin A1, J Biol Chem 279: 19755-19763 (2004).
49. N. Raben, C. Schreiner, R. Baum, S. Takikita, S. Xu, T. Xie, R. Myerowitz, M. Komatsu, J. H. Van Der Meulen, K. Nagaraju, E. Ralston and P. H. Plotz, Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder-murine Pompe disease, Autophagy 6: 1078-1089 (2010).
50. Y. Cao, J. A. Espinola, E. Fossale, A. C. Massey, A. M. Cuervo, M. E. MacDonald and S. L. Cotman, Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis, J Biol Chem 281: 20483-20493 (2006).
51. D. A. Persaud-Sawin and R. M. Boustany, Cell death pathways in juvenile Batten disease, Apoptosis 10: 973-985 (2005).
52. S. Lepine, J. C. Allegood, M. Park, P. Dent, S. Milstien and S. Spiegel, Sphingosine-1-phosphate phosphohydrolase-1 regulates ER stress-induced autophagy, Cell Death Differ 18: 350-361 (2010).
53. L. Yu, C. K. McPhee, L. Zheng, G. A. Mardones, Y. Rong, J. Peng, N. Mi, Y. Zhao, Z. Liu, F. Wan, D. W. Hailey, V. Oorschot, J. Klumperman, E. H. Baehrecke and M. J. Lenardo, Termination of autophagy and reformation of lysosomes regulated by mTOR, Nature 465: 942-946 (2010).
54. Z. Yue, L. Friedman, M. Komatsu and K. Tanaka, The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases, Biochim Biophys Acta 1793: 1496-1507 (2009).
55. K. C. Walls, A. P. Ghosh, A. V. Franklin, B. J. Klocke, M. Ballestas, J. J. Shacka, J. Zhang and K. A. Roth, Lysosome dysfunction triggers Atg7-dependent neural apoptosis, J Biol Chem 285: 10497-10507 (2010).
56. T. Fukuda, M. Ahearn, A. Roberts, R. J. Mattaliano, K. Zaal, E. Ralston, P. H. Plotz and N. Raben, Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease, Mol Ther 14: 831-839 (2006).
57. H. J. Gundersen, P. Bagger, T. F. Bendtsen, S. M. Evans, et al., The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis, APMIS 96: 857-881 (1988).
58. G. Liao, S. Cheung, J. Galeano, A. X. Ji, Q. Qin and X. Bi, Allopregnanolone treatment delays cholesterol accumulation and reduces autophagic/lysosomal dysfunction and inflammation in Npc1-/- mouse brain, Brain Res 1270: 140-151 (2009).
59. Y. T. Wu, H. L. Tan, G. Shui, C. Bauvy, Q. Huang, M. R. Wenk, C. N. Ong, P. Codogno and H. M. Shen, Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase, J Biol Chem 285: 10850-10861 (2010).
60. S. B. Narayan, D. Rakheja, J. V. Pastor, K. Rosenblatt, S. R. Greene, J. Yang, B. A. Wolf and M. J. Bennett, Over-expression of CLN3P, the Batten disease protein, inhibits PANDER-induced apoptosis in neuroblastoma cells: Further evidence that CLN3P has anti-apoptotic properties, Mol Genet Metab 88: 178-183 (2006).
61. M. Sardiello, M. Palmieri, A. di Ronza, D. L. Medina, M. Valenza, V. A. Gennarino, C. Di Malta, F. Donaudy, V. Embrione, R. S. Polishchuk, S. Banfi, G. Parenti, E. Cattaneo and A. Ballabio, A gene network regulating lysosomal biogenesis and function, Science 325: 473-477 (2009).
62. M. Sardiello and A. Ballabio, Lysosomal enhancement: a CLEAR answer to cellular degradative needs, Cell Cycle 8: 4021-4022 (2009).
63. B. Dehay, J. Bove, N. Rodriguez-Muela, C. Perier, A. Recasens, P. Boya and M. Vila, Pathogenic lysosomal depletion in Parkinson’s disease, J Neurosci 30: 12535-12544 (2010).
64. J. E. Slemmer, J. J. Shacka, M. I. Sweeney and J. T. Weber, Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging, Curr Med Chem 15: 404-414 (2008).
65. V. N. Pivtoraiko, S. L. Stone, K. A. Roth and J. J. Shacka, Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death, Antioxid Redox Signal 11: 481-496 (2009).
66. S. Singh and M. Dikshit, Apoptotic neuronal death in Parkinson’s disease: involvement of nitric oxide, Brain Res Rev 54: 233-250 (2007).
67. S. Love, L. R. Bridges and C. P. Case, Neurofibrillary tangles in Niemann-Pick disease type C, Brain 118(Pt 1): 119-129 (1995).
68. K. Venkatachalam, A. A. Long, R. Elsaesser, D. Nikolaeva, K. Broadie and C. Montell, Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells, Cell 135: 838-851 (2008).
69. H. Nakanishi, J. Zhang, M. Koike, T. Nishioku, Y. Okamoto, E. Kominami, K. von Figura, C. Peters, K. Yamamoto, P. Saftig and Y. Uchiyama, Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice, J Neurosci 21: 7526-7533 (2001).
70. C. D. Pacheco, M. J. Elrick and A. P. Lieberman, Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis, Hum Mol Genet 18: 956-965 (2009).
71. V. Khurana, I. Elson-Schwab, T. A. Fulga, K. A. Sharp, C. A. Loewen, E. Mulkearns, J. Tyynela, C. R. Scherzer and M. B. Feany, Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo, PLoS Genet 6: e1001026 (2010).
72. M. Koike, M. Shibata, Y. Ohsawa, H. Nakanishi, T. Koga, S. Kametaka, S. Waguri, T. Momoi, E. Kominami, C. Peters, K. von Figura, P. Saftig and Y. Uchiyama, Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice, Mol Cell Neurosci 22: 146-161 (2003).
73. K. C. Walls, B. J. Klocke, P. Saftig, M. Shibata, Y. Uchiyama, K. A. Roth and J. J. Shacka, Altered regulation of phosphatidylinositol 3-kinase signaling in cathep-sin D-deficient brain, Autophagy 3: 222-229 (2007).
74. J. J. Shacka, B. J. Klocke, C. Young, M. Shibata, J. W. Olney, Y. Uchiyama, P. Saftig and K. A. Roth, Cathepsin D deficiency induces persistent neurodegeneration in the absence of Bax-dependent apoptosis, J Neurosci 27: 2081-2090 (2007).
75. D. Sevlever, P. Jiang and S. H. Yen, Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species, Biochemistry 47: 9678-9687 (2008).
76. Q. Yang, H. She, M. Gearing, E. Colla, M. Lee, J. J. Shacka and Z. Mao, Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy, Science 323: 124-127 (2009).
77. J. Mitsui, I. Mizuta, A. Toyoda, R. Ashida, Y. Takahashi, J. Goto, Y. Fukuda, H. Date, A. Iwata, M. Yamamoto, N. Hattori, M. Murata, T. Toda and S. Tsuji, Mutations for Gaucher disease confer high susceptibility to Parkinson disease, Arch Neurol 66: 571-576 (2009).
78. K. S. Hruska, O. Goker-Alpan and E. Sidransky, Gaucher disease and the synucle-inopathies, J Biomed Biotechnol 78549: 1-6 (2006).
79. Y. H. Xu, Y. Sun, H. Ran, B. Quinn, D. Witte and G. A. Grabowski, Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models, Mol Genet Metab 102: 436-447 (2011).
80. O. Goker-Alpan, B. K. Stubblefield, B. I. Giasson and E. Sidransky, Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders, Acta Neuropathol 120: 641-649 (2010).
81. J. J. Shacka, K. A. Roth and J. Zhang, The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy, Front Biosci 13: 718-736 (2008).
82. V. N. Pivtoraiko, A. J. Harrington, B. J. Mader, A. M. Luker, G. A. Caldwell, K. A. Caldwell, K. A. Roth and J. J. Shacka, Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction, J Neurochem 114: 1193-1204 (2010).
83. P. Saftig, C. Peters, K. von Figura, K. Craessaerts, F. Van Leuven and B. De Strooper, Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D, J Biol Chem 271: 27241-27244 (1996).